These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery. Kawano KI; Fujishima K; Ikeda Y; Kondo K; Umemura K J Cereb Blood Flow Metab; 2000 Jun; 20(6):988-97. PubMed ID: 10894182 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban. Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048 [TBL] [Abstract][Full Text] [Related]
5. Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig. Moriguchi A; Mihara K; Aoki T; Maeda M; Tojo N; Matsuoka N; Mutoh S Eur J Pharmacol; 2004 Sep; 498(1-3):179-88. PubMed ID: 15363993 [TBL] [Abstract][Full Text] [Related]
6. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban. Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114 [TBL] [Abstract][Full Text] [Related]
7. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban. Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys. Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199 [TBL] [Abstract][Full Text] [Related]
9. Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Matsuno H; Kozawa O; Nagashima S; Kanamaru M; Uematsu T Br J Pharmacol; 1999 Jul; 127(5):1129-34. PubMed ID: 10455258 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis. Kaku S; Umemura K; Mizuno A; Yano S; Suzuki K; Kawasaki T; Nakashima M Eur J Pharmacol; 1998 Mar; 345(2):185-92. PubMed ID: 9600636 [TBL] [Abstract][Full Text] [Related]
11. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator. Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the antithrombotic effects of FK633, GPIIb/IIIa antagonist, and aspirin in a guinea pig thrombosis model. Aoki T; Cox D; Senzaki K; Seki J; Tanaka A; Takasugi H; Motoyama Y Thromb Res; 1998 Feb; 89(3):129-36. PubMed ID: 9622041 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis. Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806 [TBL] [Abstract][Full Text] [Related]